<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jang KS</submitter><funding>NHLBI NIH HHS</funding><pagination>7312-23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4520396</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>56(18)</volume><pubmed_abstract>4-[(18)F]Fluoro-m-hydroxyphenethylguanidine ([(18)F]4F-MHPG, [(18)F]1) is a new cardiac sympathetic nerve radiotracer with kinetic properties favorable for quantifying regional nerve density with PET and tracer kinetic analysis. An automated synthesis of [(18)F]1 was developed in which the intermediate 4-[(18)F]fluoro-m-tyramine ([(18)F]16) was prepared using a diaryliodonium salt precursor for nucleophilic aromatic [(18)F]fluorination. In PET imaging studies in rhesus macaque monkeys, [(18)F]1 demonstrated high quality cardiac images with low uptake in lungs and the liver. Compartmental modeling of [(18)F]1 kinetics provided net uptake rate constants Ki (mL/min/g wet), and Patlak graphical analysis of [(18)F]1 kinetics provided Patlak slopes Kp (mL/min/g). In pharmacological blocking stud</pubmed_abstract><journal>Journal of medicinal chemistry</journal><pubmed_title>4-[18F]Fluoro-m-hydroxyphenethylguanidine: a radiopharmaceutical for quantifying regional cardiac sympathetic nerve density with positron emission tomography.</pubmed_title><pmcid>PMC4520396</pmcid><funding_grant_id>R01-HL079540</funding_grant_id><funding_grant_id>R01 HL079540</funding_grant_id><pubmed_authors>Koeppe RA</pubmed_authors><pubmed_authors>Gu G</pubmed_authors><pubmed_authors>Jang KS</pubmed_authors><pubmed_authors>Sherman PS</pubmed_authors><pubmed_authors>Quesada CA</pubmed_authors><pubmed_authors>Jung YW</pubmed_authors><pubmed_authors>Raffel DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>4-[18F]Fluoro-m-hydroxyphenethylguanidine: a radiopharmaceutical for quantifying regional cardiac sympathetic nerve density with positron emission tomography.</name><description>4-[(18)F]Fluoro-m-hydroxyphenethylguanidine ([(18)F]4F-MHPG, [(18)F]1) is a new cardiac sympathetic nerve radiotracer with kinetic properties favorable for quantifying regional nerve density with PET and tracer kinetic analysis. An automated synthesis of [(18)F]1 was developed in which the intermediate 4-[(18)F]fluoro-m-tyramine ([(18)F]16) was prepared using a diaryliodonium salt precursor for nucleophilic aromatic [(18)F]fluorination. In PET imaging studies in rhesus macaque monkeys, [(18)F]1 demonstrated high quality cardiac images with low uptake in lungs and the liver. Compartmental modeling of [(18)F]1 kinetics provided net uptake rate constants Ki (mL/min/g wet), and Patlak graphical analysis of [(18)F]1 kinetics provided Patlak slopes Kp (mL/min/g). In pharmacological blocking stud</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Sep</publication><modification>2025-04-19T07:19:59.486Z</modification><creation>2019-03-27T01:56:04Z</creation></dates><accession>S-EPMC4520396</accession><cross_references><pubmed>23965035</pubmed><doi>10.1021/jm400770g</doi></cross_references></HashMap>